| Literature DB >> 32373457 |
Kentaro Tamura1,2, Manabu Suzuki1, Satoru Ishii1, Jin Takasaki1, Go Naka1, Motoyasu Iikura1, Shinyu Izumi1, Yuichiro Takeda1, Masayuki Hojo1, Haruhito Sugiyama1.
Abstract
In general, we have to assume tuberculous pleurisy when a patient presents with pleural effusion and elevated adenosine deaminase (ADA). However, other diseases need to be considered, including immunoglobulin (Ig)G4-related disease (IgG4-RD). This case involved a 65-year-old asymptomatic man with right pleural effusion showing elevated ADA. He had no articular findings or rashes. Results were negative for all autoantibodies. Pleura, mediastinal lymph nodes, and areas around the aorta and vertebra showed high uptake of 18F-fluorodeoxyglucose (FDG) on positron-emission tomography-computed tomography (PET-CT). These findings were specific for IgG4-RD. Based on the results of FDG-PET-CT, we performed thoracoscopy under local anesthesia and bronchoscopy. Pleural biopsy and culture, and other examinations including sputum and blood yielded negative findings for tuberculous pleurisy. A pleural biopsy specimen showed IgG4-positive plasma cells and fibrosis without obliterative phlebitis or storiform fibrosis, and serum IgG4 was also high. The ratio of IgG4-to IgG-positive plasma cells was under 40%, and >10 IgG4-positive cells were seen in high-power fields. This case was classed as 'possible IgG4-RD' on the comprehensive diagnostic criteria for IgG4-RD, but did not meet the diagnostic criteria for IgG4-related respiratory disease. Prednisolone proved effective against the pleural effusion. We therefore clinically diagnosed IgG4-RD with pleural effusion based on the 2019 classification criteria for IgG4-RD in the United States. Although few cases of IgG4-RD with pleural effusion have been reported, this disease needs to be considered among the differential diagnoses for high-ADA pleural effusion. FDG-PET-CT and thoracoscopy under local anesthesia may be helpful for diagnosis.Entities:
Keywords: Adenosine deaminase; IgG4-related disease; PET-CT; Pleural effusion; Thoracoscopy
Year: 2020 PMID: 32373457 PMCID: PMC7193316 DOI: 10.1016/j.rmcr.2020.101066
Source DB: PubMed Journal: Respir Med Case Rep ISSN: 2213-0071
Laboratory findings.
| <Complete blood count> | <Biochemistry> | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| White blood cells | 4950 | /μl | Na | 141 | mEq/L | |||||
| Neutrophils | 60.0 | % | K | 3.7 | mEq/L | |||||
| Lymphocytes | 29.5 | % | Cl | 107 | mEq/L | |||||
| Monocytes | 7.3 | % | BNP | 115.9 | pg/ml | |||||
| Eosinophils | 2.8 | % | <Serology> | |||||||
| Red blood cells | 401 | × 104/μl | C-reactive protein | 1.08 | mg/dl | |||||
| Hemoglobin | 12.6 | g/dl | IgG | 2183 | mg/dl | |||||
| Platelets | 25.2 | × 104/μl | IgA | 314 | mg/dl | |||||
| <Biochemistry> | IgM | 91 | mg/dl | |||||||
| Total protein | 7.6 | g/dl | C3 | 98 | mg/dl | |||||
| Albumin | 3.2 | g/dl | C4 | 104 | mg/dl | |||||
| Total bilirubin | 0.4 | mg/dl | rheumatoid factor | <3.0 | U/ml | |||||
| Aspartate aminotransferase | 24 | U/L | antinuclear antibody | 80 (Homo) | ||||||
| Alanine aminotransferase | 17 | U/L | anti-CCP antibody | 0.9 | U/ml | |||||
| Lactate dehydrogenase | 176 | U/L | IgG4 | 299 | mg/dl | |||||
| Alkaline phosphatase | 202 | U/L | CEA | 1.0 | ng/ml | |||||
| ɤGTP | 42 | U/L | sIL-2R | 956 | U/ml | |||||
| Blood urea nitrogen | 13.9 | mg/dl | KL-6 | 144 | U/ml | |||||
| Creatinine | 1.00 | mg/dl | surfactant protein-D | 33.5 | ng/ml | |||||
BNP, brain natriuretic peptide; CCP, cyclic citrullinated peptide; CEA, carcinoembryonic antigen; KL-6, sialylated carbohydrate antigen; sIL-2R, soluble interleukin-2 receptor; ɤGTP, ɤ-Glutamyltranspeptidase.
Fig. 1Changes in level of pleural effusion after treatment. Chest X-ray before treatment (A) and after treatment (B).
Fig. 2Contrast-enhanced computed tomography (CT) of the chest showed right pleural thickening, pleural effusion, mediastinal lymph node enlargement (A), and periaortitis of the abdomen and perivertebritis (B).
Fig. 318F-fluorodeoxyglucose PET-CT showed that mediastinal lymph node, periaortic, and prevertebral maximum standardized uptake value (SUVmax) was 4–6. SUVmax was 2.17 at the pleura.
Findings from thoracentesis.
| White blood cells | 4425 | /μl | Microbiological test | |
|---|---|---|---|---|
| Neutrophil | 1+ | smear | negative | |
| Lymphocyte | 2+ | culture | negative | |
| Eosinophil | – | PCR | ||
| Total protein | 6.2 | g/dl | negative | |
| Lactate dehydrogenase | 112 | U/L | negative | |
| Glucose | 126 | mg/dl | negative | |
| Amylase | 26 | U/L | cytology | Class II |
| Triglycerides | 12 | mg/dl | ||
| CEA | <0.5 | ng/ml | ||
| Adenosine deaminase | 46.6 | U/L | ||
| Hyaluronate | 6000 | ng/ml | ||
| IgG | 2869 | mg/dl | ||
| IgG4 | 492 | mg/dl |
CEA, carcinoembryonic antigen; PCR, polymerase chain reaction.
Fig. 4Thoracoscopic findings; mild pleural thickness with white and dense granular lesions, hypervascularization and redness in the cupula and lateral parietal pleura (A). Distention of capillaries on narrow-band imaging (B).
Fig. 5(A) Pleural biopsy. Infiltration of inflammatory cells with tiny lymphocytes and fibrosis. (B) Mediastinal lymph node biopsy. Infiltration of inflammatory cells with small and large lymphocytes and some plasma cells. (C) Cell block of pleural effusion. Hematoxylin and eosin staining in the top image, immunohistochemical staining for IgG in the middle image, and immunohistochemical staining for IgG4 in the bottom image. The ratio of IgG4-to IgG-positive plasma cells (IgG4/IgG) is 22.4% (A), about 50% (B), and could not be evaluated (C).
Clinicopathological features of patients with IgG4-RD pleurisy.
| Case | Age years/Sex | Symptoms | Pleural effusion | Extrathoracic lesions | ADA (U/L) | Serum IgG4 (mg/dl) | Intrathoracic findings | References |
|---|---|---|---|---|---|---|---|---|
| 1 | 81/M | DOE | both | none | 85 | 233 | 12 | |
| 2 | 70/M | DOE, cough | right | none | 75.6 | 1030 | diffuse pleural thickening | 13 |
| 3 | 43/F | DOE | right | PC, RP | 125 | partial pleural thickening with multiple nodules and redness | 14 | |
| 4 | 79/M | None | right | SG | 54.6 | 2040 | 15 | |
| 5 | 78/M | None | right | PC | 760 | milky pleural plaque | 16 | |
| 6 | 70/M | DOE | both | PC, PA | 437 | 17 | ||
| 7 | 70/M | DOE | right | none | 224 | 17 | ||
| 8 | 32/M | DOE, malaise | both | PC | 550 | 18 | ||
| 9 | 81/M | DOE | left | SG | 61.7 | 820 | 19 | |
| 10 | 50/F | fever, chest pain, malaise | left | PC | 428 | 20 | ||
| 11 | 70/M | None | left | PA | 56.7 | 352 | 21 | |
| 12 | 16/M | None | both | none | 10.7 | 1650 | 22 | |
| 13 | 48/M | DOE, fever | both | N | 23 | |||
| 14 | 71/F | DOE, cough | right | PC, PA | 684 | 24 | ||
| 15 | 69/M | chest pain | right | N | 70.6 | 2380 | 25 | |
| 16 | 29/F | DOE, chest pain | right | 136 | 26 | |||
| 17 | 78/M | fever, malaise | both | none | 46.7 | 483 | 27 | |
| 18 | 71/M | DOE | left | pituitary | 240 | 28 | ||
| 19 | 73/M | DOE | right | PC, RP | 59.8 | 1500 | 29 | |
| 20 | 68/M | Cough | left | SG, N | 104.4 | 372 | 29 | |
| 21 | 85/M | Cough | left | orbit, SG, N, stomach, gallbladder | 122 | 2740 | 30 | |
| 22 | 65/M | None | left | SG, PA | 279 | 31 | ||
| This case | 65/M | None | right | PA, RP | 46.6 | 299 | mild pleural thickness with white and dense granular lesions, hypervascularization, and redness |
ADA, adenosine deaminase; DOE, dyspnea on exertion; F, female; M, male; N, neck lymph nodes; P, pancreas; PA, periaorta; PC, pericardium; RP, retroperitoneum; SG, salivary glands.